Image Place holder

Yukihiro Nakanishi, MD, PhD

Specialty: Pathology
Program: Pathology

Call 1-888-MOFFITT
(1-888-663-3488)

Call 1-888-MOFFITT
(1-888-663-3488)

Overview

Dr. Yukihiro Nakanishi is a Senior Member in the Moffitt Cancer Center Department of Pathology. Dr. Nakanishi earned his MD and PhD at Gunma University School of Medicine, Gunma, Japan. He completed a Research Fellowship in the Department of Pathology at Massachusetts General Hospital and a Residency in Anatomic Pathology, Department of Pathology at St. Louis University Medical Center. He then completed a Fellowship in Oncologic Surgical Pathology, Department of Pathology at Roswell Park Cancer Institute and a Fellowship in Gastrointestinal Pathology, Department of Pathology at Indiana University School of Medicine. Dr. Nakanishi joins us from the Tulane University School of Medicine, Department of Pathology and Laboratory Medicine. Dr. Nakanishi’s clinical interests are in gastrointestinal pathology including the pathology of the luminal gastrointestinal tract, liver, pancreas and gallbladder. His research interests include translational/clinicopathological study of neoplastic and non-neoplastic diseases of the gastrointestinal system. 

Education & Training

Board Certification:

  • Pathology-Anatomic

Medical School:

  • Gunma University School of Medicine(MD, - MD)
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Nakanishi Y, Jetly-Shridhar R, De Felice K. A Case of Pseudomelanosis Duodeni: Striking Endoscopic Features With Subtle but Characteristic Pathologic Findings. Int J Surg Pathol. 2019 Oct.27(7):765-766. Pubmedid: 30880545.
  • Rao S, Tsai H, Tsai E, Nakanishi Y, Bulat R. Hyperinfection Syndrome as a Cause of Fatal Gastrointestinal Hemorrhage. ACG Case Rep J. 2019 Mar.6(3):1-3. Pubmedid: 31620504. Pmcid: PMC6658032.
  • Nishimura M, Saito Y, Nakanishi Y, Shia J, Lauwers GY, Wallace MB. Pathology definitions and resection strategies for early colorectal neoplasia: Eastern versus Western approaches in the post-Vienna era. Gastrointest Endosc. 2019 Dec.91(5):983-988. Pubmedid: 31874160.
  • Komiya T, Guddati AK, Nakanishi Y. Clear cell adenocarcinoma of the lung: a SEER analysis. Transl Lung Cancer Res. 2019 Apr.8(2):187-191. Pubmedid: 31106129. Pmcid: PMC6504654.
  • Peters C, Lewin E, Wu T, Nakanishi Y. "Pure" High-Grade Large Cell Neuroendocrine Carcinoma Arising from Low- and High-Grade Dysplasia of the Gallbladder: Case Report and Review of the Literature. J Gastrointest Cancer. 2018 Jul.50(4):967-971. Pubmedid: 30043226.
  • Trivedi DP, Bhagat R, Nakanishi Y, Wang A, Moroz K, Falk NK. Granulomatous Thyroiditis: A Case Report and Literature Review. Ann Clin Lab Sci. 2017 Sep.47(5):620-624. Pubmedid: 29066492.
  • Rush N, Sun H, Nakanishi Y, Mneimneh W, Kwo PY, Saxena R. Hepatic arterial buffer response: pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis. Mod Pathol. 2016 May.29(5):489-499. Pubmedid: 26916069.
  • Nakanishi Y, LeVea C, Dibaj S, Habib F, Cheney R, Kanehira K. Reappraisal of Serosal Invasion in Patients With T3 Colorectal Cancer by Elastic Stain: Clinicopathologic Study of 139 Surgical Cases With Special Reference to Peritoneal Elastic Lamina Invasion. Arch Pathol Lab Med. 2016 Jan.140(1):81-85. Pubmedid: 26717059.
  • Lewin E, Daroca P, Sikka S, Wu T, Nakanishi Y. Gastric Adenocarcinoma of the Fundic Gland Type Treated by Endoscopic Mucosal Resection: A Case Report and Review of the Literature. Case Rep Pathol. 2016 Dec.2016:8646927. Pubmedid: 27994902. Pmcid: PMC5138457.
  • Nakanishi Y, Mneimneh WS, Sey M, Al-Haddad M, DeWitt JM, Saxena R. One hundred thirteen consecutive transgastric liver biopsies for hepatic parenchymal diseases: a single-institution study. Am J Surg Pathol. 2015 Jul.39(7):968-976. Pubmedid: 25970688.
  • Nakanishi Y, Xu B, LeVea C. Oral floor and gingival metastasis of cholangiocarcinoma: a case report and review of the literature. Case Rep Pathol. 2014 Jun.2014:712912. Pubmedid: 24891967. Pmcid: PMC4033480.
  • Yagi R, Tanaka M, Sasaki K, Kamata R, Nakanishi Y, Kanai Y, Sakai R. ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion. Oncogene. 2011 Mar.30(12):1413-1421. Pubmedid: 21076469.
  • Noro S, Yamazaki N, Nakanishi Y, Yamamoto A, Sasajima Y, Kawana S. Clinicopathological significance of sentinel node biopsy in Japanese patients with cutaneous malignant melanoma. J Dermatol. 2011 Jan.38(1):76-83. Pubmedid: 21175760.
  • Mitselou A, Batistatou A, Nakanishi Y, Hirohashi S, Vougiouklakis T, Charalabopoulos K. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites. Histol Histopathol. 2010 Oct.25(10):1257-1267. Pubmedid: 20712010.
  • Ando M, Asai M, Ono T, Nakanishi Y, Asakage T, Yamasoba T. Metastases to the lingual nodes in tongue cancer: a pitfall in a conventional neck dissection. Auris Nasus Larynx. 2010 Jun.37(3):386-389. Pubmedid: 19897329.
  • Akishima-Fukasawa Y, Ino Y, Nakanishi Y, Miura A, Moriya Y, Kondo T, Kanai Y, Hirohashi S. Significance of PGP9.5 expression in cancer-associated fibroblasts for prognosis of colorectal carcinoma. Am J Clin Pathol. 2010 Jul.134(1):71-79. Pubmedid: 20551269.
  • Suzuki H, Saito Y, Oda I, Nonaka S, Nakanishi Y. Feasibility of endoscopic mucosal resection for superficial pharyngeal cancer: a minimally invasive treatment. Endoscopy. 2010 Jan.42(1):1-7. Pubmedid: 20066588.
  • Tateishi Y, Nakanishi Y, Taniguchi H, Shimoda T, Umemura S. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Mod Pathol. 2010 Aug.23(8):1068-1072. Pubmedid: 20473277.
  • Nakajima T, Enomoto S, Yamashita S, Ando T, Nakanishi Y, Nakazawa K, Oda I, Gotoda T, Ushijima T. Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J Gastroenterol. 2010 Apr.45(1):37-44. Pubmedid: 19821005.
  • Negishi A, Masuda M, Ono M, Honda K, Shitashige M, Satow R, Sakuma T, Kuwabara H, Nakanishi Y, Kanai Y, Omura K, Hirohashi S, Yamada T. Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma. Cancer Sci. 2009 Sep.100(9):1605-1611. Pubmedid: 19522851.
  • Uemura N, Nakanishi Y, Kato H, Nagino M, Hirohashi S, Kondo T. Antibody-based proteomics for esophageal cancer: Identification of proteins in the nuclear factor-kappaB pathway and mitotic checkpoint. Cancer Sci. 2009 Sep.100(9):1612-1622. Pubmedid: 19558549.
  • Takizawa K, Matsuda T, Kozu T, Eguchi T, Kato H, Nakanishi Y, Hijikata A, Saito D. Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography. J Gastroenterol Hepatol. 2009 Oct.24(10):1687-1691. Pubmedid: 19788609.
  • Uemura N, Nakanishi Y, Kato H, Saito S, Nagino M, Hirohashi S, Kondo T. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer. 2009 May.124(9):2106-2115. Pubmedid: 19142970.
  • Sekine S, Nakanishi Y, Ogawa R, Kouda S, Kanai Y. Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sites. Virchows Arch. 2009 May.454(5):513-517. Pubmedid: 19319568.
  • Kobayashi Y, Nakanishi Y, Taniguchi H, Sekine S, Igaki H, Tachimori Y, Kato H, Matsubara H, Okazumi S, Shimoda T. Histological diversity in basaloid squamous cell carcinoma of the esophagus. Dis Esophagus. 2009 Jul.22(3):231-238. Pubmedid: 18847449.
  • Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma. Oncology-Basel. 2009 Jul.77(1):53-62. Pubmedid: 19556810.
  • Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, Kaminishi M, Ushijima T. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer. 2009 Aug.115(15):3412-3426. Pubmedid: 19472401.
  • Akishima-Fukasawa Y, Nakanishi Y, Ino Y, Moriya Y, Kanai Y, Hirohashi S. Prognostic significance of CXCL12 expression in patients with colorectal carcinoma. Am J Clin Pathol. 2009 Aug.132(2):202-210. Pubmedid: 19605814.
  • Ochiai H, Nakanishi Y, Fukasawa Y, Sato Y, Yoshimura K, Moriya Y, Kanai Y, Watanabe M, Hasegawa H, Kitagawa Y, Kitajima M, Hirohashi S. A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases. Oncology-Basel. 2008 Oct.75(1-2):32-41. Pubmedid: 18728370.
  • Akasu T, Takawa M, Yamamoto S, Ishiguro S, Yamaguchi T, Fujita S, Moriya Y, Nakanishi Y. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence. Ann Surg Oncol. 2008 Oct.15(10):2668-2676. Pubmedid: 18618181.
  • Yonemori K, Tsuta K, Shimizu C, Hatanaka Y, Hashizume K, Ono M, Nakanishi Y, Hasegawa T, Miyakita Y, Narita Y, Shibui S, Fujiwara Y. Immunohistochemical profiles of brain metastases from breast cancer. J Neurooncol. 2008 Nov.90(2):223-228. Pubmedid: 18648908.
  • Ando M, Nakanishi Y, Asai M, Maeshima A, Matsuno Y. Mucoepidermoid carcinoma of the thyroid gland showing marked ciliation suggestive of its pathogenesis. Pathol Int. 2008 Nov.58(11):741-744. Pubmedid: 18844942.
  • Uekita T, Tanaka M, Takigahira M, Miyazawa Y, Nakanishi Y, Kanai Y, Yanagihara K, Sakai R. CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma. Am J Pathol. 2008 Jun.172(6):1729-1739. Pubmedid: 18467693. Pmcid: PMC2408431.
  • Suzuki H, Nakanishi Y, Taniguchi H, Shimoda T, Yamaguchi H, Igaki H, Tachimori Y, Kato H. Two cases of early-stage esophageal malignant melanoma with long-term survival. Pathol Int. 2008 Jul.58(7):432-435. Pubmedid: 18577112.
  • Saito Y, Takisawa H, Suzuki H, Takizawa K, Yokoi C, Nonaka S, Matsuda T, Nakanishi Y, Kato K. Endoscopic submucosal dissection of recurrent or residual superficial esophageal cancer after chemoradiotherapy. Gastrointest Endosc. 2008 Feb.67(2):355-359. Pubmedid: 18226703.
  • Batistatou A, Charalabopoulos K, Nakanishi Y, Vagianos C, Hirohashi S, Agnantis NJ, Scopa CD. Differential expression of dysadherin in papillary thyroid carcinoma and microcarcinoma: correlation with E-cadherin. Endocr Pathol. 2008 Aug.19(3):197-202. Pubmedid: 18677652.
  • Nakanishi Y, Saka M, Eguchi T, Sekine S, Taniguchi H, Shimoda T. Distribution and significance of the oesophageal and gastric cardiac mucosae: a study of 131 operation specimens. Histopathology. 2007 Oct.51(4):515-519. Pubmedid: 17711448.
  • Batistatou A, Peschos D, Tsanou H, Charalabopoulos A, Nakanishi Y, Hirohashi S, Agnantis NJ, Charalabopoulos K. In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin. Brit J Cancer. 2007 May.96(9):1404-1408. Pubmedid: 17437014. Pmcid: PMC2360179.
  • Nunobe S, Nakanishi Y, Taniguchi H, Sasako M, Sano T, Kato H, Yamagishi H, Sekine S, Shimoda T. Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia. Pathol Int. 2007 Jun.57(6):315-321. Pubmedid: 17539961.
  • Takahashi K, Kohno T, Matsumoto S, Nakanishi Y, Arai Y, Fujiwara T, Tanaka N, Yokota J. Clonality and heterogeneity of pulmonary blastoma from the viewpoint of genetic alterations: a case report. Lung Cancer. 2007 Jul.57(1):103-108. Pubmedid: 17350138.
  • Nobeyama Y, Okochi-Takada E, Furuta J, Miyagi Y, Kikuchi K, Yamamoto A, Nakanishi Y, Nakagawa H, Ushijima T. Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas. Int J Cancer. 2007 Jul.121(2):301-307. Pubmedid: 17372906.
  • Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Am J Surg Pathol. 2007 Jan.31(1):85-94. Pubmedid: 17197923.
  • Uehara K, Nakanishi Y, Shimoda T, Taniguchi H, Akasu T, Moriya Y. Clinicopathological significance of microscopic abscess formation at the invasive margin of advanced low rectal cancer. Br J Surg. 2007 Feb.94(2):239-243. Pubmedid: 17094167.
  • Sentani K, Nakanishi Y, Ojima H, Hamaguchi T, Shimoda T. Esophageal squamous cell carcinoma presenting with systemic arterial embolism. Pathol Int. 2007 Feb.57(2):96-100. Pubmedid: 17300674.
  • Uehara K, Shimoda T, Nakanishi Y, Taniguchi H, Akasu T, Fujita S, Yamamoto S, Moriya Y. Clinicopathological significance of fibrous tissue around fixed recurrent rectal cancer in the pelvis. Br J Surg. 2007 Dec.94(12):1530-1535. Pubmedid: 17854114.
  • Batistatou A, Makrydimas G, Zagorianakou N, Zagorianakou P, Nakanishi Y, Agnantis NJ, Hirohashi S, Charalabopoulos K. Expression of dysadherin and E-cadherin in trophoblastic tissue in normal and abnormal pregnancies. Placenta. 2007 Aug.28(5-6):590-592. Pubmedid: 17084448.
  • Matsumoto S, Takahashi K, Iwakawa R, Matsuno Y, Nakanishi Y, Kohno T, Shimizu E, Yokota J. Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int J Cancer. 2006 Sep.119(6):1491-1494. Pubmedid: 16642476.
  • Usui T, Aoyagi K, Saeki N, Nakanishi Y, Kanai Y, Ohki M, Ogawa K, Yoshida T, Sasaki H. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells. Int J Oncol. 2006 Oct.29(4):779-784. Pubmedid: 16964375.
  • Nishizawa A, Nakanishi Y, Sasajima Y, Yamazaki N, Yamamoto A. Syringoid eccrine carcinoma with apparently aggressive transformation: case report and review of the literature. Int J Dermatol. 2006 Oct.45(10):1218-1221. Pubmedid: 17040446.
  • Hotta K, Shimoda T, Nakanishi Y, Saito D. Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids. Pathol Int. 2006 Oct.56(10):591-596. Pubmedid: 16984615.
  • Takada H, Imoto I, Tsuda H, Nakanishi Y, Sakakura C, Mitsufuji S, Hirohashi S, Inazawa J. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis. Oncogene. 2006 Oct.25(49):6554-6562. Pubmedid: 16715143.
  • Kim DH, Muto M, Kuwahara Y, Nakanishi Y, Watanabe H, Aoyagi K, Ogawa K, Yoshida T, Sasaki H. Array-based comparative genomic hybridization of circulating esophageal tumor cells. Oncol Rep. 2006 Nov.16(5):1053-1059. Pubmedid: 17016592.
  • Mihara M, Yoshida Y, Tsukamoto T, Inada K, Nakanishi Y, Yagi Y, Imai K, Sugimura T, Tatematsu M, Ushijima T. Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins. Am J Pathol. 2006 Nov.169(5):1643-1651. Pubmedid: 17071588. Pmcid: PMC1780214.
  • Eguchi T, Nakanishi Y, Shimoda T, Iwasaki M, Igaki H, Tachimori Y, Kato H, Yamaguchi H, Saito D, Umemura S. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006 Mar.19(3):475-480. Pubmedid: 16444191.
  • Huang JF, Takayasu K, Okada S, Shimada K, Nakanishi Y, Ikeda M. Primary hepatocellular carcinoma detected long after tumor markers and lymph node metastases--beyond our vision?. Digest Dis Sci. 2006 Mar.51(3):610-615. Pubmedid: 16614975.
  • Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ, Charalabopoulos K. Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. Virchows Arch. 2006 Jun.448(6):763-767. Pubmedid: 16570180.
  • Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Iwasaki H, Sonobe H, Goto H, Kusakabe H, Takahira T, Kobayashi C, Kawaguchi K, Saito T, Yamamoto H, Tamiya S, Iwamoto Y, Tsuneyoshi M. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Mod Pathol. 2006 Jun.19(6):820-831. Pubmedid: 16557275.
  • Fukaya M, Isohata N, Ohta H, Aoyagi K, Ochiya T, Saeki N, Yanagihara K, Nakanishi Y, Taniguchi H, Sakamoto H, Shimoda T, Nimura Y, Yoshida T, Sasaki H. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology. 2006 Jul.131(1):14-29. Pubmedid: 16831586.
  • Takahashi H, Aoyagi K, Nakanishi Y, Sasaki H, Yoshida T, Honda H. Classification of intramural metastases and lymph node metastases of esophageal cancer from gene expression based on boosting and projective adaptive resonance theory. J Biosci Bioeng. 2006 Jul.102(1):46-52. Pubmedid: 16952836.
  • Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ, Nakanishi Y, Hirohashi S, Charalabopoulos K. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol. 2006 Feb.30(2):185-193. Pubmedid: 16434892.
  • Nishizawa A, Nakanishi Y, Sasajima Y, Yamazaki N, Yamamoto A. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature. Am J Dermatopathxxx. 2006 Feb.28(1):56-59. Pubmedid: 16456327.
  • Hatakeyama H, Kondo T, Fujii K, Nakanishi Y, Kato H, Fukuda S, Hirohashi S. Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics. 2006 Dec.6(23):6300-6316. Pubmedid: 17133371.
  • Igaki H, Kato H, Tachimori Y, Nakanishi Y, Shimoda T. Surgery for clinical T3 carcinomas of the upper thoracic oesophagus and the need for new strategies. Br J Surg. 2005 Oct.92(10):1235-1240. Pubmedid: 15997441.
  • Fujimoto Y, Nakanishi Y, Sekine S, Yoshimura K, Akasu T, Moriya Y, Shimoda T. CD10 expression in colorectal carcinoma correlates with liver metastasis. Dis Colon Rectum. 2005 Oct.48(10):1883-1889. Pubmedid: 16175325.
  • Tominaga K, Nakanishi Y, Nimura S, Yoshimura K, Sakai Y, Shimoda T. Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum. 2005 Jan.48(1):92-100. Pubmedid: 15690664.
  • Takada H, Imoto I, Tsuda H, Nakanishi Y, Ichikura T, Mochizuki H, Mitsufuji S, Hosoda F, Hirohashi S, Ohki M, Inazawa J. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Oncogene. 2005 Dec.24(54):8051-8060. Pubmedid: 16103878.
  • Batistatou A, Scopa CD, Ravazoula P, Nakanishi Y, Peschos D, Agnantis NJ, Hirohashi S, Charalabopoulos KA. Involvement of dysadherin and E-cadherin in the development of testicular tumours. Brit J Cancer. 2005 Dec.93(12):1382-1387. Pubmedid: 16333245. Pmcid: PMC2361540.
  • Nishizawa A, Nakanishi Y, Yoshimura K, Sasajima Y, Yamazaki N, Yamamoto A, Hanada K, Kanai Y, Hirohashi S. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients. Cancer. 2005 Apr.103(8):1693-1700. Pubmedid: 15751018.
  • Nitori N, Ino Y, Nakanishi Y, Yamada T, Honda K, Yanagihara K, Kosuge T, Kanai Y, Kitajima M, Hirohashi S. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2005 Apr.11(7):2531-2539. Pubmedid: 15814630.
  • Akimoto S, Nakanishi Y, Sakamoto M, Kanai Y, Hirohashi S. Laminin 5 beta3 and gamma2 chains are frequently coexpressed in cancer cells. Pathol Int. 2004 Sep.54(9):688-692. Pubmedid: 15363037.
  • Sekine S, Shimoda T, Nimura S, Nakanishi Y, Akasu T, Katai H, Gotoda T, Shibata T, Sakamoto M, Hirohashi S. High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles. Mod Pathol. 2004 Nov.17(11):1421-1426. Pubmedid: 15494708.
  • Yachida S, Nakanishi Y, Shimoda T, Nimura S, Igaki H, Tachimori Y, Kato H. Adenosquamous carcinoma of the esophagus. Clinicopathologic study of 18 cases. Oncology-Basel. 2004 Jun.66(3):218-225. Pubmedid: 15218313.
  • Hamaguchi T, Matsumura Y, Nakanishi Y, Muro K, Yamada Y, Shimada Y, Shirao K, Niki H, Hosokawa S, Tagawa T, Kakizoe T. Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts. Cancer Sci. 2004 Jul.95(7):608-613. Pubmedid: 15245599.
  • Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol. 2004 Feb.164(2):689-699. Pubmedid: 14742272. Pmcid: PMC1602280.
  • Nakanishi Y, Akimoto S, Sato Y, Kanai Y, Sakamoto M, Hirohashi S. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Appl Immunohistochem Mol Morphol. 2004 Dec.12(4):323-328. Pubmedid: 15536331.
  • Shimada Y, Yamasaki S, Hashimoto Y, Ito T, Kawamura J, Soma T, Ino Y, Nakanishi Y, Sakamoto M, Hirohashi S, Imamura M. Clinical significance of dysadherin expression in gastric cancer patients. Clin Cancer Res. 2004 Apr.10(8):2818-2823. Pubmedid: 15102690.
  • Kanai Y, Ushijima S, Nakanishi Y, Sakamoto M, Hirohashi S. Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Lett. 2003 Mar.192(1):75-82. Pubmedid: 12637155.
  • Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer. 2003 Mar.6(1):39-48. Pubmedid: 12673425.
  • Aoki S, Shimamura T, Shibata T, Nakanishi Y, Moriya Y, Sato Y, Kitajima M, Sakamoto M, Hirohashi S. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Brit J Cancer. 2003 Mar.88(5):726-732. Pubmedid: 12618882. Pmcid: PMC2376346.
  • Yachida S, Fukushima N, Nakanishi Y, Akasu T, Kitamura H, Sakamoto M, Shimoda T. Alpha-fetoprotein-producing carcinoma of the colon: report of a case and review of the literature. Dis Colon Rectum. 2003 Jun.46(6):826-831. Pubmedid: 12794586.
  • Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil. J Cancer Res Clin Oncol. 2003 Dec.129(12):683-690. Pubmedid: 14576935.
  • Fujii H, Ichikawa K, Takagaki T, Nakanishi Y, Ikegami M, Hirose S, Shimoda T. Genetic evolution of alpha fetoprotein producing gastric cancer. J Clin Pathol. 2003 Dec.56(12):942-949. Pubmedid: 14645355. Pmcid: PMC1770145.
  • Igaki H, Kato H, Tachimori Y, Nakanishi Y. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Surgery. 2003 Apr.133(4):368-374. Pubmedid: 12717353.
  • Aoki S, Nakanishi Y, Akimoto S, Moriya Y, Yoshimura K, Kitajima M, Sakamoto M, Hirohashi S. Prognostic significance of laminin-5 gamma2 chain expression in colorectal carcinoma: immunohistochemical analysis of 103 cases. Dis Colon Rectum. 2002 Nov.45(11):1520-1527. Pubmedid: 12432301.
  • Sugiura T, Kato H, Tachimori Y, Igaki H, Yamaguchi H, Nakanishi Y. Second primary carcinoma in the gastric tube constructed as an esophageal substitute after esophagectomy. J Am Coll Surg. 2002 May.194(5):578-583. Pubmedid: 12022598.
  • Yachida S, Fukushima N, Nakanishi Y, Nimura S, Sato M, Shimada K, Miura K, Sakamoto M. Phosphoglyceride crystal deposition disease presenting as multiple paragastric masses. Digest Dis Sci. 2002 Jun.47(6):1413-1418. Pubmedid: 12064820.
  • Katoh K, Nakanishi Y, Akimoto S, Yoshimura K, Takagi M, Sakamoto M, Hirohashi S. Correlation between laminin-5 gamma2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue. Oncology-Basel. 2002 Jul.62(4):318-326. Pubmedid: 12138239.
  • Kaneda A, Kaminishi M, Nakanishi Y, Sugimura T, Ushijima T. Reduced expression of the insulin-induced protein 1 and p41 Arp2/3 complex genes in human gastric cancers. Int J Cancer. 2002 Jul.100(1):57-62. Pubmedid: 12115587.
  • Ono Y, Nakanishi Y, Gotoh M, Sakamoto M, Hirohashi S. Epidermal growth factor receptor gene amplification is correlated with laminin-5 gamma2 chain expression in oral squamous cell carcinoma cell lines. Cancer Lett. 2002 Jan.175(2):197-204. Pubmedid: 11741748.
  • Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M, Hirohashi S. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Am J Pathol. 2002 Dec.161(6):1997-2001. Pubmedid: 12466115. Pmcid: PMC1850925.
  • Kubo M, Sakamoto M, Fukushima N, Yachida S, Nakanishi Y, Shimoda T, Yamamoto J, Moriya Y, Hirohashi S. Less aggressive features of colorectal cancer with liver metastases showing macroscopic intrabiliary extension. Pathol Int. 2002 Aug.52(8):514-518. Pubmedid: 12366810.
  • Tanaka M, Shibui S, Kobayashi Y, Nomura K, Nakanishi Y. A graft-versus-tumor effect in a patient with ependymoma who received an allogenic bone marrow transplant for therapy-related leukemia. Case report. J Neurosurg. 2002 Aug.97(2):474-476. Pubmedid: 12186480.
  • Hishida T, Nakanishi Y, Shimoda T, Igaki H, Tachimori Y, Kato H, Yamaguchi H, Iinuma G. Esophageal basaloid carcinoma with marked myoepithelial differentiation. Pathol Int. 2002 Apr.52(4):313-317. Pubmedid: 12031088.
  • Sekine S, Shibata T, Yamauchi Y, Nakanishi Y, Shimoda T, Sakamoto M, Hirohashi S. Beta-catenin mutations in sporadic fundic gland polyps. Virchows Arch. 2002 Apr.440(4):381-386. Pubmedid: 11956818.
  • Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology-Basel. 2001 Sep.61(3):212-220. Pubmedid: 11574777.
  • Kubota K, Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Nakanishi Y, Iinuma G. Surgical therapy for recurrent esophageal cancers at anastomoses after esophagectomy. Hepatogastroenterology. 2001 Sep.48(41):1364-1367. Pubmedid: 11677965.
  • Nakanishi Y, Ochiai A, Kato H, Tachimori Y, Igaki H, Hirohashi S. Clinicopathological significance of tumor nest configuration in patients with esophageal squamous cell carcinoma. Cancer. 2001 Mar.91(6):1114-1120. Pubmedid: 11267956.
  • Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int. 2001 Mar.51(3):165-171. Pubmedid: 11328531.
  • Tanaka M, Shibui S, Nomura K, Nakanishi Y. Radiotherapy combined with nimustine hydrochloride and etoposide for malignant gliomas: results of a pilot study. Jpn J Clin Oncol. 2001 Jun.31(6):246-250. Pubmedid: 11463801.
  • Igaki H, Kato H, Tachimori Y, Sato H, Daiko H, Nakanishi Y. Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg. 2001 Jun.19(6):887-893. Pubmedid: 11404147.
  • Tajima Y, Nakanishi Y, Yoshino T, Kokawa A, Kusano M, Shimoda T. Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus. Oncology-Basel. 2001 Jul.61(1):1-9. Pubmedid: 11474241.
  • Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer. 2001 Jan.91(2):205-212. Pubmedid: 11146446.
  • Ishikawa M, Nakanishi Y, Yamazaki N, Yamamoto A. Malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2001 Jan.27(1):67-70. Pubmedid: 11231249.
  • Igaki H, Kato H, Tachimori Y, Daiko H, Fukaya M, Yajima S, Nakanishi Y. Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg. 2001 Dec.20(6):1089-1094. Pubmedid: 11717009.
  • Fukagawa T, Sasako M, Mann GB, Sano T, Katai H, Maruyama K, Nakanishi Y, Shimoda T. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer. 2001 Aug.92(4):753-760. Pubmedid: 11550144.
  • Igaki H, Kato H, Tachimori Y, Nakanishi Y. Cervical lymph node metastasis in patients with submucosal carcinoma of the thoracic esophagus. J Surg Oncol. 2000 Sep.75(1):37-41. Pubmedid: 11025460.
  • Hokamura N, Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Nakanishi Y. Preoperative chemotherapy for esophageal carcinoma with intramural metastasis. J Surg Oncol. 2000 Oct.75(2):117-121. Pubmedid: 11064391.
  • Kanamoto A, Nakanishi Y, Ochiai A, Shimoda T, Yamaguchi H, Tachimori Y, Kato H, Watanabe H. A case of small polypoid esophageal carcinoma with multidirectional differentiation, including neuroendocrine, squamous, ciliated glandular, and sarcomatous components. Arch Pathol Lab Med. 2000 Nov.124(11):1685-1687. Pubmedid: 11079026.
  • Tajima Y, Nakanishi Y, Ochiai A, Tachimori Y, Kato H, Watanabe H, Yamaguchi H, Yoshimura K, Kusano M, Shimoda T. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000 Mar.88(6):1285-1293. Pubmedid: 10717608.
  • Fujii K, Moriya Y, Fujita S, Akasu T, Miyake H, Nakanishi Y, Saito T. Dermatomyositis accompanied by rectal cancer: report of a case. Surg Today. 2000 Mar.30(3):302-304. Pubmedid: 10752789.
  • Tajima Y, Nakanishi Y, Tachimori Y, Kato H, Watanabe H, Yamaguchi H, Yoshimura K, Kusano M, Shimoda T. Significance of involvement by squamous cell carcinoma of the ducts of esophageal submucosal glands. Analysis of 201 surgically resected superficial squamous cell carcinomas. Cancer. 2000 Jul.89(2):248-254. Pubmedid: 10918152.
  • Okano K, Yamamoto J, Kosuge T, Yamamoto S, Sakamoto M, Nakanishi Y, Hirohashi S. Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases. Cancer. 2000 Jul.89(2):267-275. Pubmedid: 10918155.
  • Gotoda T, Matsumura Y, Kondo H, Ono H, Kanamoto A, Kato H, Watanabe H, Tachimori Y, Nakanishi Y, Kakizoe T. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut. 2000 Jan.46(1):14-19. Pubmedid: 10601048. Pmcid: PMC1727790.
  • Tanaka M, Shibui S, Nomura K, Nakanishi Y, Hasegawa T, Hirose T. Malignant intracerebral nerve sheath tumor with intratumoral calcification. Case report. J Neurosurg. 2000 Feb.92(2):338-341. Pubmedid: 10659023.
  • Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000 Dec.3(4):219-225. Pubmedid: 11984739.
  • Kanamoto A, Yamaguchi H, Nakanishi Y, Tachimori Y, Kato H, Watanabe H. Clinicopathological study of multiple superficial oesophageal carcinoma. Br J Surg. 2000 Dec.87(12):1712-1715. Pubmedid: 11122190.
  • Kato H, Igaki H, Tachimori Y, Watanabe H, Tsubosa Y, Nakanishi Y. Assessment of cervical lymph node metastasis in the staging of thoracic esophageal carcinoma. J Surg Oncol. 2000 Aug.74(4):282-285. Pubmedid: 10962461.
  • Takayasu K, Yoshie K, Muramatsu Y, Iwata R, Nakanishi Y, Sakamoto M, Fukuda H, Satake M, Moriyama N, Makino Y. Haemodynamic changes in non-alcoholic (viral) liver cirrhosis studied by computed tomography (CT) arterial portography and CT arteriography. J Gastroenterol Hepatol. 1999 Sep.14(9):908-914. Pubmedid: 10535474.
  • Masui F, Matsuno Y, Yokoyama R, Nakanishi Y, Hasegawa T, Kanai Y, Beppu Y, Hirohashi S, Fujii K, Shimoda T. Synovial sarcoma, histologically mimicking primitive neuroectodermal tumor/Ewing's sarcoma at distant sites. Jpn J Clin Oncol. 1999 Sep.29(9):438-441. Pubmedid: 10563198.
  • Hokamura N, Kato H, Watanabe H, Tachimori Y, Shimoda T, Nakanishi Y. Fulminant nonocclusive mesenteric ischemia developing just after esophagectomy. Hepatogastroenterology. 1999 Sep.46(29):2865-2867. Pubmedid: 10576362.
  • Tanaka M, Shibui S, Nomura K, Nakanishi Y. Pineal ganglioneuroblastoma in an adult. J Neurooncol. 1999 Sep.44(2):169-173. Pubmedid: 10619501.
  • Kanamoto A, Kato H, Tachimori Y, Watanabe H, Nakanishi Y, Kondo H, Yamaguchi H, Gotoda T, Muro K, Matsumura Y. No prognostic significance of p53 expression in esophageal squamous cell carcinoma. J Surg Oncol. 1999 Oct.72(2):94-98. Pubmedid: 10518106.
  • Nakanishi Y, Ochiai A, Yamauchi Y, Moriya Y, Yoshimura K, Hirohashi S. Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology-Basel. 1999 Nov.57(4):276-280. Pubmedid: 10575311.
  • Kanai Y, Ushijima S, Nakanishi Y, Hirohashi S. Reduced mRNA expression of the DNA demethylase, MBD2, in human colorectal and stomach cancers. Biochem Bioph Res Co. 1999 Nov.264(3):962-966. Pubmedid: 10544038.
  • Tanaka M, Shibui S, Nomura K, Nakanishi Y. Brain metastases from adenoendocrine carcinoma of the common bile duct: a case report. Jpn J Clin Oncol. 1999 May.29(5):252-255. Pubmedid: 10379337.
  • Yamazaki N, Yamamoto A, Wada T, Ishikawa M, Moriya Y, Nakanishi Y. A case of metastatic extramammary Paget's disease that responded to combination chemotherapy. J Dermatol. 1999 May.26(5):311-316. Pubmedid: 10380432.
  • Ono Y, Nakanishi Y, Ino Y, Niki T, Yamada T, Yoshimura K, Saikawa M, Nakajima T, Hirohashi S. Clinocopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: immunohistochemical analysis of 67 lesions. Cancer. 1999 Jun.85(11):2315-2321. Pubmedid: 10357399.
  • Kurisu Y, Shimoda T, Ochiai A, Nakanishi Y, Hirata I, Katsu KI. Histologic and immunohistochemical analysis of early submucosal invasive carcinoma of the colon and rectum. Pathol Int. 1999 Jul.49(7):608-616. Pubmedid: 10504521.
  • Mita T, Nakanishi Y, Ochiai A, Shimoda T, Kato H, Yamaguchi H, Toda G. Paraneoplastic vasculitis associated with esophageal carcinoma. Pathol Int. 1999 Jul.49(7):643-647. Pubmedid: 10504526.
  • Nakanishi Y, Ochiai A, Shimoda T, Yamaguchi H, Tachimori Y, Kato H, Watanabe H, Hirohashi S. Heterotopic sebaceous glands in the esophagus: histopathological and immunohistochemical study of a resected esophagus. Pathol Int. 1999 Apr.49(4):364-368. Pubmedid: 10365859.
  • Tanaka M, Shibui S, Nomura K, Nakanishi Y. Solitary plasmacytoma of the skull: a case report. Jpn J Clin Oncol. 1998 Oct.28(10):626-630. Pubmedid: 9839504.
  • Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Ishikawa T, Nakanishi Y, Ochiai A. Anastomotic recurrence of oesophageal squamous cell carcinoma after transthoracic oesophagectomy. Eur J Surg. 1998 Oct.164(10):759-764. Pubmedid: 9840305.
  • Ishii H, Okada S, Okusaka T, Yoshimori M, Nakasuka H, Shimada K, Yamasaki S, Nakanishi Y, Sakamoto M. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer. 1998 May.82(9):1638-1642. Pubmedid: 9576282.
  • Kubota K, Akasu T, Nakanishi Y, Sugihara K, Fujita S, Moriya Y. Perianal Paget's disease associated with rectal carcinoma: a case report. Jpn J Clin Oncol. 1998 May.28(5):347-350. Pubmedid: 9703865.
  • Nakanishi Y, Matsuno Y, Shimoda T, Wada T, Yamazaki N, Yamamoto A, Hirohashi S. Eccrine porocarcinoma with melanocyte colonization. Br J Dermatol. 1998 Mar.138(3):519-521. Pubmedid: 9580812.
  • Noda N, Sasako M, Yamaguchi N, Nakanishi Y. Ignoring small lymph nodes can be a major cause of staging error in gastric cancer. Br J Surg. 1998 Jun.85(6):831-834. Pubmedid: 9667718.
  • Nakasuka H, Okada S, Okusaka T, Ishii H, Ikeda M, Ito R, Kosakamoto H, Yoshimori M, Nakanishi Y, Sakamoto M. Undifferentiated carcinoma of the liver with neuroendocrine features: a case report. Jpn J Clin Oncol. 1998 Jun.28(6):401-404. Pubmedid: 9730157.
  • Okusaka T, Okada S, Ishii H, Ikeda M, Nakasuka H, Nagahama H, Iwata R, Furukawa H, Takayasu K, Nakanishi Y, Sakamoto M, Hirohashi S, Yoshimori M. Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma. Oncology-Basel. 1998 Jul.55(4):276-283. Pubmedid: 9663415.
  • Sasaki H, Ishizuka T, Muto M, Nezu M, Nakanishi Y, Inagaki Y, Watanabe H, Watanabe H, Terada M. Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer Res. 1998 Jul.58(14):2991-2995. Pubmedid: 9679961.
  • Nakanishi Y, Ochiai A, Yoshimura K, Kato H, Shimoda T, Yamaguchi H, Tachimori Y, Watanabe H, Hirohashi S. The clinicopathologic significance of small areas unstained by Lugol's iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases. Cancer. 1998 Apr.82(8):1454-1459. Pubmedid: 9554520.
  • Fujii K, Nakanishi Y, Ochiai A, Tsuda H, Yamaguchi H, Tachimori Y, Kato H, Watanabe H, Shimoda T. Solitary esophageal metastasis of breast cancer with 15 years' latency: a case report and review of the literature. Pathol Int. 1997 Sep.47(9):614-617. Pubmedid: 9311012.
  • Muramatsu Y, Takayasu K, Furukawa Y, Miyakawa K, Iwata R, Ushio K, Yamamoto J, Nakanishi Y. Hepatic tumor invasion of bile ducts: wedge-shaped sign on MR images. Radiology. 1997 Oct.205(1):81-85. Pubmedid: 9314966.
  • Murata S, Kato H, Tamura H, Tachimori Y, Watanabe H, Yamaguchi H, Nakanishi Y. Second primary carcinoma in the residual cervical esophagus after thoracic esophagectomy: report of five cases. J Surg Oncol. 1997 Oct.66(2):130-133. Pubmedid: 9354170.
  • Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, Yamamoto S, Hirohashi S. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology-Basel. 1997 May.54(2):158-165. Pubmedid: 9075789.
  • Nakanishi Y, Ochiai A, Shimoda T, Yamaguchi H, Tachimori Y, Kato H, Watanabe H, Hirohashi S. Epidermization in the esophageal mucosa: unusual epithelial changes clearly detected by Lugol's staining. Am J Surg Pathol. 1997 May.21(5):605-609. Pubmedid: 9158687.
  • Sano T, Sasako M, Kinoshita T, Katai H, Maruyama K, Takenaka T, Nakanishi Y. Total gastrectomy for primary gastric lymphoma at stages IE and IIE: a prospective study of fifty cases. Surgery. 1997 May.121(5):501-505. Pubmedid: 9142147.
  • Murata S, Fujita S, Sugihara K, Akasu T, Moriya Y, Nakanishi Y. Sclerosing sweat duct carcinoma in the peri-anal skin: a case report. Jpn J Clin Oncol. 1997 Jun.27(3):197-199. Pubmedid: 9255278.
  • Mizobuchi S, Tachimori Y, Kato H, Watanabe H, Nakanishi Y, Ochiai A. Metastatic esophageal tumors from distant primary lesions: report of three esophagectomies and study of 1835 autopsy cases. Jpn J Clin Oncol. 1997 Dec.27(6):410-414. Pubmedid: 9438004.
  • Ochiai T, Yamamoto J, Kosuge T, Shimada K, Takayama T, Yamasaki S, Ozaki H, Nakanishi Y, Mukai K. Adenosquamous carcinoma with different morphologic and histologic components arising from the intrahepatic bile duct: report of a case. Hepatogastroenterology. 1996 May.43(9):663-666. Pubmedid: 8799412.
  • Nagane M, Shibui S, Nishikawa R, Oyama H, Nakanishi Y, Nomura K. Triple primary malignant neoplasms including a malignant brain tumor: report of two cases and review of the literature. Surg Neurol. 1996 Mar.45(3):219-229. Pubmedid: 8638217.
  • Kato H, Tachimori Y, Watanabe H, Igaki H, Nakanishi Y, Ochiai A. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection. J Surg Oncol. 1996 Apr.61(4):267-272. Pubmedid: 8627996.
  • Koga H, Ochiai A, Nakanishi Y, Sasako M, Mizuno S, Kinoshita T, Maruyama K, Hirohashi S. Reevaluation of prognostic factors in gastric leiomyosarcoma. Am J Gastroenterol. 1995 Aug.90(8):1307-1312. Pubmedid: 7639235.
  • Nakanishi Y, Noguchi M, Matsuno Y, Saikawa M, Mukai K, Shimosato Y, Hirohashi S. p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract. Immunohistochemical analysis of 95 lesions. Cancer. 1995 Apr.75(7):1657-1662. Pubmedid: 8826924.
  • Nagane M, Oyama H, Shibui S, Nomura K, Nakanishi Y, Kamiya M. Ossified and calcified epidural hematoma incidentally found 40 years after head injury: case report. Surg Neurol. 1994 Jul.42(1):65-69. Pubmedid: 7940099.
  • Noguchi M, Maezawa N, Nakanishi Y, Matsuno Y, Shimosato Y, Hirohashi S. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas. Diagn Mol Pathol. 1993 Mar.2(1):29-35. Pubmedid: 8287223.
  • Rim KS, Sakamoto M, Watanabe H, Matsuno Y, Nakanishi Y, Mukai K, Hirohashi S. Pathology and DNA cytophotometry of small hepatocellular carcinoma with a nodule-in-nodule appearance--evidence for stepwise progression of hepatocellular carcinoma. Jpn J Clin Oncol. 1993 Feb.23(1):26-33. Pubmedid: 8384672.
  • Sasaki A, Nakanishi Y, Nakazato Y, Yamaguchi H. Application of lectin and B-lymphocyte-specific monoclonal antibodies for the demonstration of human microglia in formalin-fixed, paraffin-embedded brain tissue. Virchows Arch A Pathol Anat Histopathol. 1991 Jul.419(4):291-299. Pubmedid: 1719695.
  • Nakazato Y, Hirato J, Nakanishi Y, Tamaki O, Yazaki C. Immunohistochemical localization of five classes of intermediate filament in a benign pelvic soft tissue tumor of rhabdoid appearance. Acta Pathol Jpn. 1991 Jan.41(1):65-72. Pubmedid: 1709554.
  • Ogawa A, Sugihara S, Nakanishi Y, Suzuki S, Sasaki A, Hirato J, Nakazato Y. Intermediate filament expression in non-neoplastic pituitary cells. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989 Dec.58(5):331-340. Pubmedid: 1692652.

Patient Comments
Overall Satisfaction
0

0 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments